Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study

Fig. 3

Profiles of BALF (A) and serum (B) concentration of hCAP/LL-37 between frail and robust patients and the profiles of BALF (C, E) and serum (D, F) concentration of SP-A and SP-D between frail and robust patients. hCAP/LL-37 = human cationic antimicrobial protein and its C-terminal 37 amino acid fragment; BALF, bronchoalveolar lavage fluid; SP-A, surfactant protein A; SP-D, surfactant protein D. n = 24 (frail patients) and 45 (robust patients)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us